Skip to content
10-Q

Quarterly Report

CONSTELLATION PHARMACEUTICALS INC

0001564590-21-025723

← back to feed
Filed
May 10, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2021 · Apr 30, 2021 47.91M sh
Capex Q1 2021 · Mar 31, 2021 $490K
Capex Q1 2021 · Mar 31, 2020 $38K
Operating Cash Flow Q1 2021 · Mar 31, 2021 −$39.74M
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$26.03M
Cash And Equivalents Q1 2021 · Mar 31, 2021 $113.98M
Cash And Equivalents Q1 2021 · Dec 31, 2020 $163.69M
Stockholders Equity Q1 2021 · Mar 31, 2021 $377.32M
Stockholders Equity Q1 2021 · Dec 31, 2020 $410.72M
Stockholders Equity Q1 2021 · Mar 31, 2020 $315.53M
Stockholders Equity Q1 2021 · Dec 31, 2019 $337.58M
Current Liabilities Q1 2021 · Mar 31, 2021 $25.34M
Current Liabilities Q1 2021 · Dec 31, 2020 $30.55M
Total Liabilities Q1 2021 · Mar 31, 2021 $25.34M
Total Liabilities Q1 2021 · Dec 31, 2020 $31.13M
Current Assets Q1 2021 · Mar 31, 2021 $389.95M
Current Assets Q1 2021 · Dec 31, 2020 $428.61M
Total Assets Q1 2021 · Mar 31, 2021 $402.66M
Total Assets Q1 2021 · Dec 31, 2020 $441.85M
Sga Expense Q1 2021 · Mar 31, 2021 $9.44M
Sga Expense Q1 2021 · Mar 31, 2020 $5.91M
Rd Expense Q1 2021 · Mar 31, 2021 $30.78M
Rd Expense Q1 2021 · Mar 31, 2020 $20.08M
Net Income Q1 2021 · Mar 31, 2021 −$40.07M
Net Income Q1 2021 · Dec 31, 2020 −$126.4M
Net Income Q1 2021 · Mar 31, 2020 −$25.44M
Operating Income Q1 2021 · Mar 31, 2021 −$40.23M
Operating Income Q1 2021 · Mar 31, 2020 −$25.98M